Latest GREAT POINT PARTNERS LLC Stock Portfolio
$522Million– No. of Holdings #33
GREAT POINT PARTNERS LLC Performance:
2024 Q2: -5.05%YTD: 10.2%2023: 5.9%
Performance for 2024 Q2 is -5.05%, and YTD is 10.2%, and 2023 is 5.9%.
About GREAT POINT PARTNERS LLC and 13F Hedge Fund Stock Holdings
GREAT POINT PARTNERS LLC is a hedge fund based in GREENWICH, CT. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.9 Billions. In it's latest 13F Holdings report, GREAT POINT PARTNERS LLC reported an equity portfolio of $522 Millions as of 30 Jun, 2024.
The top stock holdings of GREAT POINT PARTNERS LLC are URGN, , . The fund has invested 9.3% of it's portfolio in UROGEN PHARMA LTD and 7% of portfolio in NEUROGENE INC.
The fund managers got completely rid off ALPINE IMMUNE SCIENCES INC (ALPN), APOGEE THERAPEUTICS INC and AEROVATE THERAPEUTICS INC (AVTE) stocks. They significantly reduced their stock positions in ANAPTYSBIO INC (ANAB), INSMED INC (INSM) and VIRIDIAN THERAPEUTICS INC (VRDN). GREAT POINT PARTNERS LLC opened new stock positions in KALVISTA PHARMACEUTICALS INC (KALV), IONIS PHARMACEUTICALS INC (IONS) and CONTEXT THERAPEUTICS INC (CNTX). The fund showed a lot of confidence in some stocks as they added substantially to KYVERNA THERAPEUTICS INC, AUTOLUS THERAPEUTICS PLC (AUTL) and CYTOKINETICS INC (CYTK).
The top stock holdings of GREAT POINT PARTNERS LLC are URGN, , . The fund has invested 9.3% of it's portfolio in UROGEN PHARMA LTD and 7% of portfolio in NEUROGENE INC.
The fund managers got completely rid off ALPINE IMMUNE SCIENCES INC (ALPN), APOGEE THERAPEUTICS INC and AEROVATE THERAPEUTICS INC (AVTE) stocks. They significantly reduced their stock positions in ANAPTYSBIO INC (ANAB), INSMED INC (INSM) and VIRIDIAN THERAPEUTICS INC (VRDN). GREAT POINT PARTNERS LLC opened new stock positions in KALVISTA PHARMACEUTICALS INC (KALV), IONIS PHARMACEUTICALS INC (IONS) and CONTEXT THERAPEUTICS INC (CNTX). The fund showed a lot of confidence in some stocks as they added substantially to KYVERNA THERAPEUTICS INC, AUTOLUS THERAPEUTICS PLC (AUTL) and CYTOKINETICS INC (CYTK).
GREAT POINT PARTNERS LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
GREAT POINT PARTNERS LLC Annual Return Estimates Vs S&P 500
Our best estimate is that GREAT POINT PARTNERS LLC made a return of -5.05% in the last quarter. In trailing 12 months, it's portfolio return was 28.26%.
New Buys
| Ticker | $ Bought |
|---|---|
| kalvista pharmaceuticals inc | 15,768,300 |
| ionis pharmaceuticals inc | 15,727,800 |
| context therapeutics inc | 14,875,800 |
| voyager therapeutics inc | 12,668,100 |
| olema pharmaceuticals inc | 8,622,240 |
| tscan therapeutics inc | 5,503,860 |
| lexicon pharmaceuticals inc | 50,400 |
New stocks bought by GREAT POINT PARTNERS LLC
Additions
| Ticker | % Inc. |
|---|---|
| kyverna therapeutics inc | 232 |
| autolus therapeutics plc | 195 |
| cytokinetics inc | 134 |
| merus n v | 134 |
| dynavax technologies corp | 87.68 |
| zura bio ltd | 68.33 |
| arcellx inc | 64.00 |
| optinose inc | 56.23 |
Additions to existing portfolio by GREAT POINT PARTNERS LLC
Reductions
| Ticker | % Reduced |
|---|---|
| anaptysbio inc | -97.44 |
| insmed inc | -67.77 |
| viridian therapeutics inc | -62.55 |
| esperion therapeutics inc ne | -27.61 |
| vistagen therapeutics inc | -17.72 |
| terns pharmaceuticals inc | -12.26 |
| jasper therapeutics inc | -1.36 |
| abivax sa | -0.65 |
GREAT POINT PARTNERS LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| mind medicine mindmed inc | -18,800,000 |
| ocular therapeutix inc | -15,731,400 |
| alpine immune sciences inc | -44,733,700 |
| aerovate therapeutics inc | -26,249,000 |
| xenon pharmaceuticals inc | -19,637,200 |
| apogee therapeutics inc | -26,580,000 |
| intra-cellular therapies inc | -10,380,000 |
| immunocore hldgs plc | -7,475,000 |
GREAT POINT PARTNERS LLC got rid off the above stocks
Sector Distribution
GREAT POINT PARTNERS LLC has about 77.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 77.2 |
| Others | 22.8 |
Market Cap. Distribution
GREAT POINT PARTNERS LLC has about 3.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 39.1 |
| UNALLOCATED | 25.1 |
| MID-CAP | 21.9 |
| MICRO-CAP | 10.7 |
| LARGE-CAP | 3.2 |
Stocks belong to which Index?
About 56.3% of the stocks held by GREAT POINT PARTNERS LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 56.3 |
| Others | 43.7 |
GREAT POINT PARTNERS LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC has 33 stocks in it's portfolio. About 58% of the portfolio is in top 10 stocks. PLRX proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for GREAT POINT PARTNERS LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 5.20 | 492,000 | 27,153,500 | added | 64.00 | ||
| AGLE | spyre therapeutics inc | 0.61 | 134,612 | 3,164,730 | added | 7.69 | ||
| ALPN | alpine immune sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANAB | anaptysbio inc | 0.12 | 25,000 | 626,500 | reduced | -97.44 | ||
| ARVN | arvinas inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AUTL | autolus therapeutics plc | 2.29 | 3,441,670 | 11,977,000 | added | 195 | ||
| AVTE | aerovate therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CNTX | context therapeutics inc | 2.85 | 7,419,360 | 14,875,800 | new | |||
| CYTK | cytokinetics inc | 4.92 | 474,202 | 25,692,300 | added | 134 | ||
| DVAX | dynavax technologies corp | 5.11 | 2,374,000 | 26,660,000 | added | 87.68 | ||
| EOLS | evolus inc | 5.10 | 2,451,770 | 26,601,700 | added | 0.07 | ||
| ESPR | esperion therapeutics inc ne | 2.46 | 5,791,590 | 12,857,300 | reduced | -27.61 | ||
| FOLD | amicus therapeutics inc | 2.84 | 1,495,500 | 14,835,400 | unchanged | 0.00 | ||
| IMCR | immunocore hldgs plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| INSM | insmed inc | 3.21 | 250,000 | 16,750,000 | reduced | -67.77 | ||
| IONS | ionis pharmaceuticals inc | 3.01 | 330,000 | 15,727,800 | new | |||
| ITCI | intra-cellular therapies inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| JSPR | jasper therapeutics inc | 1.75 | 402,015 | 9,125,740 | reduced | -1.36 | ||
| KALV | kalvista pharmaceuticals inc | 3.02 | 1,338,570 | 15,768,300 | new | |||
| LXRX | lexicon pharmaceuticals inc | 0.01 | 30,000 | 50,400 | new | |||